We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report World - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

World - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Global Vaccine Market 2024

Vaccine Market Size

After six years of growth, the global vaccine market decreased by -16.2% to $X in 2022. Overall, consumption, however, recorded a prominent increase. As a result, consumption reached the peak level of $X, and then reduced rapidly in the following year.

Vaccine Production

In value terms, vaccine production rose modestly to $X in 2022 estimated in export price. Overall, production, however, continues to indicate a resilient increase. The growth pace was the most rapid in 2018 with an increase of 30%. Over the period under review, global production attained the peak level at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Vaccine Exports

Exports

In 2022, global exports of vaccines for human medicine shrank significantly to X tons, which is down by -34.4% against 2021. In general, exports, however, recorded a temperate expansion. The growth pace was the most rapid in 2021 when exports increased by 72%. As a result, the exports attained the peak of X tons, and then contracted markedly in the following year.

In value terms, vaccine exports contracted remarkably to $X in 2022. Over the period under review, exports, however, saw a remarkable increase. The most prominent rate of growth was recorded in 2021 with an increase of 113%. As a result, the exports reached the peak of $X, and then fell rapidly in the following year.

Exports by Country

In 2022, Ireland (X tons), distantly followed by Belgium (X tons), France (X tons), the United States (X tons) and India (X tons) were the key exporters of vaccines for human medicine, together constituting 85% of total exports. The following exporters - the Netherlands (X tons) and South Korea (X tons) - together made up 5.2% of total exports.

From 2012 to 2022, the biggest increases were recorded for India (with a CAGR of +11.1%), while shipments for the other global leaders experienced more modest paces of growth.

In value terms, Belgium ($X) remains the largest vaccine supplier worldwide, comprising 45% of global exports. The second position in the ranking was taken by the United States ($X), with a 17% share of global exports. It was followed by France, with a 9.9% share.

From 2012 to 2022, the average annual growth rate of value in Belgium amounted to +17.4%. In the other countries, the average annual rates were as follows: the United States (+12.6% per year) and France (+2.4% per year).

Export Prices by Country

In 2022, the average vaccine export price amounted to $X per ton, increasing by 11% against the previous year. Overall, export price indicated a remarkable increase from 2012 to 2022: its price increased at an average annual rate of +6.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, vaccine export price increased by +72.8% against 2019 indices. The pace of growth was the most pronounced in 2013 an increase of 39% against the previous year. The global export price peaked in 2022 and is expected to retain growth in the immediate term.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Belgium ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Belgium (+9.2%), while the other global leaders experienced more modest paces of growth.

Vaccine Imports

Imports

After four years of growth, supplies from abroad of vaccines for human medicine decreased by -48.3% to X tons in 2022. Overall, imports, however, continue to indicate tangible growth. The growth pace was the most rapid in 2021 with an increase of 88%. As a result, imports attained the peak of X tons, and then shrank significantly in the following year.

In value terms, vaccine imports dropped notably to $X in 2022. Over the period under review, imports, however, enjoyed strong growth. The most prominent rate of growth was recorded in 2021 when imports increased by 129%. As a result, imports reached the peak of $X, and then declined markedly in the following year.

Imports by Country

The countries with the highest levels of vaccine imports in 2022 were France (X tons), Canada (X tons), the UK (X tons), the Netherlands (X tons), Germany (X tons), the Philippines (X tons), China (X tons), the United States (X tons), Nigeria (X tons), South Africa (X tons), the United Arab Emirates (X tons) and Brazil (X tons), together recording 51% of total import. The Dominican Republic (X tons) took a minor share of total imports.

From 2012 to 2022, the biggest increases were recorded for the Dominican Republic (with a CAGR of +38.3%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the largest vaccine importing markets worldwide were the United States ($X), Germany ($X) and China ($X), with a combined 33% share of global imports. The UK, France, the Netherlands, Brazil, Canada, Nigeria, the United Arab Emirates, the Philippines, South Africa and the Dominican Republic lagged somewhat behind, together comprising a further 27%.

The Dominican Republic, with a CAGR of +35.0%, recorded the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average vaccine import price amounted to $X per ton, with an increase of 12% against the previous year. Over the period under review, import price indicated a pronounced expansion from 2012 to 2022: its price increased at an average annual rate of +4.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, vaccine import price increased by +36.8% against 2020 indices. The most prominent rate of growth was recorded in 2021 when the average import price increased by 22% against the previous year. Over the period under review, average import prices reached the peak figure in 2022 and is likely to see steady growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United States ($X per ton), while the Dominican Republic ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+15.4%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of vaccines consumption in 2020 were China, the United States and Japan, together accounting for 44% of global consumption. India, Germany, Russia, Nigeria, Indonesia, the Netherlands, Mexico, France, Pakistan and Canada lagged somewhat behind, together accounting for a further 32%.
The countries with the highest volumes of vaccines production in 2020 were Ireland, China and the United States, with a combined 46% share of global production.
In value terms, Belgium remains the largest vaccines supplier worldwide, comprising 36% of global exports. The second position in the ranking was occupied by Ireland, with a 16% share of global exports. It was followed by France, with a 14% share.
In value terms, Belgium, the United States and China constituted the countries with the highest levels of imports in 2020, together comprising 48% of global imports. These countries were followed by Germany, Nigeria, the Netherlands, the UK, Ireland, Brazil, Spain, France, Canada and Pakistan, which together accounted for a further 25%.
In 2020, the average vaccines export price amounted to $295,521 per ton, picking up by 6.9% against the previous year.
The average vaccines import price stood at $456,702 per ton in 2020, falling by -16.4% against the previous year.

This report provides an in-depth analysis of the global vaccine market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Company coverage:

Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Merck & Co., GlaxoSmithKline, Sanofi, Chongqing Zhifei Biological Products Co., CureVac N.V., Roche Holding AG, Seqirus, Serum Institute Of India, Sinovac, Sinopharm, Fiocruz, Grupo Insud, The Commonwealth Serum Laboratories, Shionogi & Co., Mitsubishi Tanabe Pharma Corp., IMV Inc., Medicago, Valneva

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. GLOBAL PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. GLOBAL IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. GLOBAL EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 382

This report provides an in-depth analysis of the vaccine market in Asia.

U.S. - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 459

This report provides an in-depth analysis of the vaccine market in the U.S..

China - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 423

This report provides an in-depth analysis of the vaccine market in China.

EU - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 439

This report provides an in-depth analysis of the vaccine market in the EU.

Free Data: Vaccines For Human Medicine - World
Table
Vaccines For Human Medicine - World - Table
Dashboard
Vaccines For Human Medicine - World - Dashboard
Report
Vaccines For Human Medicine - World - Report